Comments: NJ S1030 | 2022-2023 | Regular Session

Bill Title: Permits certain managed care organizations to consider cost-effectiveness when placing prescription drug on formulary.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-01-31 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1030 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey S1030 at this time.

Social Comments on NJ S1030

feedback